Patents

US 7928092 B2: Formulations and methods of treating inflammatory bowel disease

Granted
2011-04-19
Filed
2010-06-10 application 12797655
Type
Utility · 9 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Methods and formulations for treating inflammatory bowel disease are disclosed. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of 4-aminosalicylic acid and/or 5-aminosalicylic acid to affected areas of the intestine. The methods and formulations comprise modified-release elements, providing for drug delivery to the affected or desired area. Diseases and conditions treatable with the present invention include Crohn's disease and ulcerative colitis.

Source: PVGPATDIS, file of 2026-04-10 (ipg110419.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
AGI Therapeutics Limited 1 patentsNot reportedAthlone, IEPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
John DevaneAthlone, IE16PVGPATDIS, file of 2026-04-10
Jackie ButlerAthlone, IE1PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K9/2059PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/00PVGPATDIS, file of 2026-04-10
C07CAcyclic or carbocyclic compoundsC07C245/08PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2018-02-22Correction
Corrective assignment to correct the us patent no. 8,050,873 previously recorded on reel 040183 frame 0129. assignor(s) hereby confirms the assignment.
WARNER CHILCOTT COMPANY, LLC signed 2015-12-31ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 1745417/593PASDL, file of 2026-10-15
2016-09-29Assignment
Assignment of assignor's interest
WARNER CHILCOTT COMPANY, LLC signed 2015-12-31ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 1740183/129PASDL, file of 2026-10-15
2011-09-15Assignment
Assignment of assignor's interest
AGI THERAPEUTICS LTD. signed 2011-07-21WARNER CHILCOTT COMPANY, LLC FAJARDO, PR26909/548ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.